TIGAR inhibits ischemia/reperfusion-induced inflammatory response of astrocytes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TIGAR inhibits ischemia/reperfusion-induced inflammatory response of astrocytes

Published:2018-03 Issue: Volume:131 Page:377-388
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Chen Jieyu,Zhang Ding-Mei,Feng Xing,Wang Jian,Qin Yuan-Yuan,Zhang Tian,Huang Qiao,Sheng Rui,Chen Zhong,Li Mei,Qin Zheng-Hong

Funder

Natural Science foundation of China

Jiangsu Provincial Medical Youth Talent

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference31 articles.

1. Cytokines and acute neurodegeneration;Allan;Nat. Rev. Neurosci.,2001

2. TIGAR, a p53-inducible regulator of glycolysis and apoptosis;Bensaad;Cell,2006

3. Nuclear heme oxygenase-1 (HO-1) modulates subcellular distribution and activation of Nrf2, impacting metabolic and anti-oxidant defenses;Biswas;J. Biol. Chem.,2014

4. Role of oxidants in ischemic brain damage;Chan;Stroke,1996

5. Astrocytes and brain injury;Chen;J. Cerebr. Blood Flow Metabol.,2003

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. REV-ERBα Mitigates Astrocyte Activation and Protects Dopaminergic Neurons from Damage;Journal of Molecular Neuroscience;2024-09-10

2. Metabolic Reprogramming in Gliocyte Post-cerebral Ischemia/ Reperfusion: From Pathophysiology to Therapeutic Potential;Current Neuropharmacology;2024-08

3. Research progress on immune-related therapeutic targets of brain injury caused by cerebral ischemia;Cytokine;2024-08

4. Exploring the therapeutic efficacy and pharmacological mechanism of Guizhi Fuling Pill on ischemic stroke: a meta-analysis and network pharmacology analysis;Metabolic Brain Disease;2024-07-25

5. Disruption of TIGAR-TAK1 alleviates immunopathology in a murine model of sepsis;Nature Communications;2024-05-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3